US20040096821A1 - Detection of micro-organisms - Google Patents

Detection of micro-organisms Download PDF

Info

Publication number
US20040096821A1
US20040096821A1 US10/467,440 US46744003A US2004096821A1 US 20040096821 A1 US20040096821 A1 US 20040096821A1 US 46744003 A US46744003 A US 46744003A US 2004096821 A1 US2004096821 A1 US 2004096821A1
Authority
US
United States
Prior art keywords
membranes
sample
micro
specific binding
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/467,440
Other languages
English (en)
Inventor
Elizabeth Keenan
Michael Brennand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0102790A external-priority patent/GB0102790D0/en
Priority claimed from GB0126674A external-priority patent/GB0126674D0/en
Application filed by Individual filed Critical Individual
Assigned to MICAP PLC reassignment MICAP PLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRENNAND, MICHAEL S., KEENAN, ELIZABETH ANN
Publication of US20040096821A1 publication Critical patent/US20040096821A1/en
Priority to US11/382,725 priority Critical patent/US8956880B2/en
Assigned to MILLIPORE CORPORATION reassignment MILLIPORE CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MICAP PLC
Assigned to EMD MILLIPORE CORPORATION reassignment EMD MILLIPORE CORPORATION CHANGE OF NAME Assignors: MILLIPORE CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02—Hollow fibre modules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02—Hollow fibre modules
    • B01D63/024—Hollow fibre modules with a single potted end
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08—Hollow fibre membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/10—Supported membranes; Membrane supports
    • B01D69/105—Support pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/14—Dynamic membranes
    • B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
    • B01D69/142—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers"
    • B01D69/144—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers" containing embedded or bound biomolecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/26—Polyalkenes
    • B01D71/262—Polypropylene
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/30—Cross-linking

Definitions

  • the present invention concerns improved methods for detecting micro-organisms particularly yeast and bacteria in colloidal mixtures such as beer. It is also concerned with detecting micro-organisms in air and solid samples (such as food or bacterial spores) which can be placed in a liquid phase suspension or dissolved.
  • the production of foodstuff and beverages such as beer is accompanied by testing for the presence of certain micro-organisms in order to ensure the quality of the end-product.
  • the brewing process may for example require in-line testing every few hours of a sample having a volume of at least 25 ml, and preferably sample volumes of for example 250 ml.
  • Particulate matter which may include micro-organisms, namely yeast and bacteria, must then be separated from the sample and then tested to determine the presence or absence of specific micro-organisms.
  • Devices used to achieve this include the Bibby disposable vacuum filter unit having a flat filter with an average pore diameter of 0.45 um and the Nalgene filter holders with receivers, having a flat filter with an average pore diameter of 0.45 um or 0.2 um (see for example Merck Laboratory Supplies Catalogue 1998, p. 482).
  • Such devices allow the filtration of maximum sample volumes of only 100 ml, have a flat surface area of 50 cm2 and can take up to 30 minutes to test a sample due to their complexity of use. Once their maximum volume has been filtered, they become blocked by particulate matter such as proteins present in the sample fluid (e.g. lager, ales and other colloidal solutions) and any subsequent filtration would require pressures so high as to cause cell lysis, preventing the detection of the micro-organisms and giving false results.
  • WO 01/11006 discloses improvements to the prior art allowing more rapid separation and detection of micro-organisms, as well as relatively simple and easy subsequent recovery of, and thus testing for, micro-organisms.
  • the devices and methods of the present invention are distinct from those of WO 01/11006, and in particular (as detailed below) the methods involve a washing step rather than just a resuspension step.
  • the devices and methods of the present invention further improve upon WO 01/11006 and the other prior art by providing a yet more rapid and simple method for the separation and detection of micro-organisms from a sample.
  • the devices of the present invention can rapidly detect all of the bacteria in e.g. a 100 ml volume of test solution containing as few as 1-3 bacteria. Similar results can also be achieved with larger volumes e.g. 1000 ml of lager containing 1-3 bacteria.
  • a method for detecting the presence of a micro-organism in a fluid sample comprising the steps of:
  • a filter device comprising a plurality of hollow fibre filter membranes which have attached to them a first member of a specific binding pair, said micro-organism displaying the second member of said specific binding pair, said membranes having first and second ends, an outer surface and an inner surface defining a lumen, said first end of each of said membranes being open and communicating with said sample inlet and flow through said second end of each of said membranes being restricted such that said flow occurs only through said first end and the pores of said membranes, the sample mixture being filtered through the pores of said membranes, leaving a filtrand in said lumen of said membranes;
  • the sample may for example have a volume of at least 25, 50, 100, 200, 250, 300, 400, 500, 600, 700, 750, 800, 900 or 1000 ml.
  • a “member of a specific binding pair” is one of two different molecules, having an area on the surface or in a cavity which specifically binds to and is thereby defined as complementary with a particular spatial and polar organization of the other molecule.
  • the members of the specific binding pair are commonly referred to as ligand and receptor (antiligand), sbp member and sbp partner, sbp members or the like. These are usually members of an immunological pair such as antigen-antibody, although the term does have a broader meaning encompassing other specific binding pairs.
  • antibody in its various grammatical forms is used herein to refer to immunoglobulin molecules and immunologically active portions of immunoglobulin molecules, i.e., molecules that contain an antibody combining site or paratope. Such molecules are also referred to as “antigen binding fragments” of immunoglobulin molecules.
  • first member of the specific binding pair is physically constrained and prevented or hindered from separating from the membrane. This may be by means of covalent binding to the membrane, for example of an antibody to the membrane, or it may be by other means, for example van der Waals'forces. Thus a first member of a specific binding pair, such as an antibody, may simply be trapped by the fibres of a membrane, and need not be covalently bound to it.
  • antibodies and other first members of specific binding pairs may be covalently bound to polypropylene membranes by cross linking them with glutaraldehyde.
  • Methods of cross-linking will be readily apparent to a person skilled in the art and can be achieved by e.g. oxidation or halogenation of the polypropylene groups to a reactive monomer.
  • an air (i.e. gas) filtration device having a pore diameter sufficient to entrap the chosen micro-organism.
  • a pore size e.g. 0.2 pm may be used.
  • the air filtration device may also comprise a fan to encourage the flow of air through the filter, and a large volume of air can be passed through the filter in a relatively small period of time, all particulate matter of a greater size than the pore diameter being retained.
  • the filter is then contacted with a sample fluid (e.g.
  • sample fluid such as a buffer or other solution, fluid or mixture in which the given micro-organism can be solubilised or suspended is dependent upon the nature of the micro-organism itself and the first member of the specific binding pair used in step (i) above.
  • the function of the sample fluid is to enable the given micro-organism to interact with the first member of the specific binding pair such that the specific binding pair can be formed as appropriate to allow the detection of the given micro-organism.
  • the first member of the specific binding pair may form a specific binding pair with the or a given micro-organism, and thus its detection can be effected, the formation of a specific pair being correlated with the presence of the given micro-organism.
  • a solid such as a foodstuff (e.g. cake or bread) for the presence of a given micro-organism
  • the solid is contacted with a sample fluid in which the micro-organism can be suspended or solubilised, and any entrapped micro-organisms are placed into suspension or solubilised as appropriate.
  • the rest of the method of the present invention can then be worked (i.e. steps (i)-(iv) as defined above).
  • a method for detecting the presence of a micro-organism in a solid sample comprising the steps of: a) contacting said solid sample with a sample fluid such that said micro-organism is placed in fluid-phase, to give a fluid sample; and b) performing the method of steps (i)-(iv) upon said fluid sample.
  • the present invention provides apparatus comprising a first chamber into which said package may be placed, a second chamber containing sample fluid, means (such as a pump or syringe) to alter the relative pressure in said first and second chambers, said second chamber communicating with said first chamber by means of a piercing implement having a lumen through which flow may occur.
  • the present invention also provides a method for testing the contents of a package for the presence of a given micro-organism, comprising placing said package in said first chamber, altering the relative air pressure in said first and second chambers, and contacting said package with said piercing implement such that said package is pierced and solid matter in said package, particularly particulate matter, passes from said package to said sample fluid and is suspended or solubilised in said sample fluid to give a fluid sample.
  • the method of steps (i)-(iv) is then performed with the fluid sample and any micro-organisms therein detected.
  • the method may additionally comprise the step of effecting a relative gaseous pressure change in said first and second chambers such that the pressure in said first chamber is greater than that in said second chamber.
  • the movement of any solid matter, such as particulate matter, from the package in the first chamber to the second chamber can thereby be encouraged or effected.
  • the package In order to allow the package to be safely removed from said apparatus, it may be provided with a self-sealing pad which is contacted with the piercing implement-upon its removal from the piercing implement the pad will self-seal, preventing any further egress of solid from the package and making it safe to remove from the apparatus.
  • the piercing implement may be sealed such that the seal is broken upon piercing of the package-in this way it is possible to maintain a pressure difference between the first and second chambers, the pressure being reduced in the second chamber relative to that in the first. Alternatively, the pressure in the chambers can be altered after piercing has occurred.
  • the piercing implement may be self-sealing.
  • a method for testing the contents of a package for the presence of a given micro-organism comprising placing said package in said first chamber, contacting said package with said piercing implement such that said package is pierced and solid matter in said package, particularly particulate matter, is able to pass from said package to said sample buffer (or said another solution, fluid or mixture into which the given micro-organism can be suspended or solubilised), and reducing the air pressure in said second chamber relative to that in said first chamber, such that said solid matter passes from said package to said sample buffer and is suspended or solubilised in said sample buffer (or said other solution, fluid or mixture into which the given micro-organism can be suspended or solubilised).
  • the present invention provides the distinct advantage of giving rapid and accurate results.
  • the time taken for a sample assay can be many times less than other comparable assays such as ELISA and PCR.
  • a typical assay time using the present invention is 15 minutes.
  • the present invention with its testing of fluid samples for the presence of micro-organisms can of course also be used for the testing of fluid samples for the presence of e.g. anthrax with the use of e.g. an anti-anthrax antibody as the first member of a specific binding pair.
  • the present invention can also be used to test for any other micro-organisms which may be used in biological warfare.
  • the sample is passed through the filter membranes under conditions which allow for binding of the first and second members of the specific binding pair.
  • conditions which allow for binding of the first and second members of the specific binding pair.
  • more stringent binding also referred to as “stringent hybridisation”
  • the temperature or pH may be varied to provide stringent hybridisation conditions. Appropriate hybridisation conditions will depend upon the nature of the members of the specific binding pair and will be readily apparent to one skilled in the art.
  • wash step (ii) it is obviously essential that bound specific binding pairs are not washed from the lumen of the membranes, and so the washing step removes the filtrand other than any second members of the specific binding pair which have bound to the first members of the specific binding pair attached to the membranes. It is of course possible that, occasionally, a specific binding pair could become detached from the membranes and washed, together with the unbound filtrand, from the lumen of the membranes. Although this may occasionally happen, substantially all (i.e. essentially all) of the first members of the specific binding pair having bound to them second members of the specific binding pair remain attached to the membranes.
  • the detection step (iii) may take one of many forms.
  • the specific binding pair may be detected by the binding to the pair or to the micro-organism of a labelled probe, for example a detection antibody which incorporates an enzyme (the classical enzyme immunosorbent assay, EIA).
  • the probe may be a radiolabelled antibody or a fluorescently labelled antibody.
  • Other probes will be readily apparent to a person skilled in the art.
  • the micro-organism may be eluted (i.e. separated) from the first member of the specific binding pair and a separate detection step employed.
  • eluted micro-organism can be lysed and any ATP released detected using a luciferase assay.
  • micro-organism specific antibodies may be used, or the eluate can be plated out on a general (or micro-organism specific) nutrient culture and the growth of any micro-organism colonies detected.
  • the eluate may also be tested using oligonucleotide probes specific to the micro-organism in a conventional PCR test.
  • the range of detection steps available for use in the present invention also means that the membranes may have attached to them first members of a plurality of specific binding pairs.
  • the different first members may be mixed together and attached throughout the membranes, or first members of a given specific binding pair may be attached to the membranes at a specific position.
  • the detection step employed may allow the general detection and/or quantification of the specific binding pairs, or it may allow the detection and/or quantification of a chosen specific binding pair or pairs.
  • the presence of a first specific binding pair could be detected using a first fluorophore, and the presence of a second specific binding pair detected using a radiolabel, or by the use of a second fluorophore having an excitation and/or emission spectrum distinguishable from that of the first fluorophore.
  • Prior art devices typically present filtered particulate matter as a hard “biscuit” (a relatively highly compressed high density block of particulate matter) on a membrane surface, micro-organisms and other particulate matter blocking and being trapped in membrane interstices. This biscuit is difficult to remove and difficult to process to enable it to be tested for the presence of micro-organisms.
  • the configuration of the devices of the present invention results in the formation of a resuspendable “cake” which can be subsequently washed away, and allows the use of lower pressures during filtration, which in turn prevents the formation of a dense biscuit and the need for higher pressures. If operated at higher pressures, lysis of bacteria can occur, in turn giving incorrect results. High pressure can also cause distortion of bacteria, allowing them to pass through the membrane and giving incorrect results.
  • Prior art filtration device and methods include those of GB 2135902, EP 302949, WO 94/00222, WO 84/00015, U.S. Pat. No. 5,863,501, U.S. Pat. No. 5,814,179, U.S. Pat. No. 4,501,793, JP 4-135478 (WPI Abstract 1992-205001), JP 63-104615 (WPI Abstract 1988-165566), JP 63-088007 (WPI Abstract 1988-145060) and JP 61-133105 (WPI Abstract 1986-200908).
  • WPI Abstract 1992-205001 JP 63-104615
  • JP 63-088007 WPI Abstract 1988-145060
  • JP 61-133105 WPI Abstract 1986-200908
  • JP 63-104615 discloses a device for separating e.g. viruses from fluids, comprising a plurality of porous hollow cellulose fibres, one end of them being embedded in a filler material and open to the atmosphere, and the other end being sealed.
  • Other filtration devices are also known from e.g. the “CultureGard Hollow Fiber Filter” from Cole Parmer (www. coleparmer. com), product code EW-295 10-50.
  • polypropylene fibre membranes may be used (the Cole Parmer product above uses cellulose hollow fibre membranes).
  • membranes can be treated with a wetting agent such as iso-propanol and/or a detergent such as Tween-20 to make them more hydrophilic and susceptible to the attachment of the first member of the specific binding pair.
  • a wetting agent such as iso-propanol and/or a detergent such as Tween-20
  • Tween-20 a detergent
  • FIG. 1 For example, a membrane can be soaked in iso-propanol and then allowed to dry, prior to treatment with Tween 20 (typically, 0.1%) and antibody.
  • Useful detergents include non-ionic detergents, particularly Tween 20, more particularly a solution of 5% Tween 20.
  • the use of a plurality of hollow fibre filter membranes also provides a relatively large surface area (typically at least three times as much) across which filtration may take place, when compared to the surface area provided by a single device of similar overall dimensions (i.e. size) having a single flat membrane. This also allows for the filtering of a relatively large volume of sample prior to any blockage of pores occurring. This is particularly useful with turbid samples (e.g. stout) which contain large amounts of particulate matter which can rapidly block flat filter membranes.
  • turbid samples e.g. stout
  • the exact nature of the filter membrane material has also been found to be important—commercially available polypropylene hollow fibre membranes having an average pore diameter of 0.2 um pre-treated with iso-propanol have been found to allow much greater flow rates than e.g. polysulfone membranes having an average pore diameter of 0.2 m, even when identically pre-treated.
  • the hollow fibre membrane is a polypropylene membrane.
  • other membranes may also be used, particularly those having similar physical characteristics e.g. a similar average pore diameter and area of pores per unit area of membrane surface, and these include the likes of polysulfone, cellulose acetate and nylon membranes.
  • Hollow fibre membranes used in the present invention may have an average pore diameter of 0.2 urn.
  • a device having a sample inlet and a plurality of hollow fibre filter membranes which have attached to them a first member of a specific binding pair, the second member of said specific binding pair being displayed by a given micro-organism, said membranes having first and second ends, an outer surface and an inner surface defining a lumen, said first end of each of said membranes being open and communicating with said sample inlet and flow through said second end of each of said membranes being restricted such that said flow occurs only through said first end and the pores of said membranes, such that a sample mixture passed into said device through said sample inlet is filtered through the pores of said membranes, leaving a filtrand in said lumen of said membranes.
  • the present invention allows for the detection of specific micro-organisms in a given volume of sample fluid in a fraction of the time required by other devices, and is frequently at least ten times as fast.
  • the present invention also provides the important advantage of providing consistent results for a given sample, even when a highly turbid mixture is being filtered-at least 99% consistency between different sets of results is readily achievable. This compares favourably to results obtained using flat membranes, which can be relatively inconsistent.
  • the hollow fibre membranes consist of polypropylene, which is used in many biomedical applications due to its low capacity for absorbing proteins. It has not been previously suggested that polypropylene membranes should have antibody or other members of specific binding pairs attached to them.
  • the present invention shows that by treating the polypropylene membranes with iso-propanol as described herein, the specific binding pair members remain attached to the membranes even when washed with detergents such as SDS and Tween-20. This has not previously been suggested.
  • FIG. 1 shows first device according to the present invention and its use in a method of detection of micro-organisms
  • FIG. 2 shows a section through an end cap and a top view of a collar of the device of FIG. 1;
  • FIG. 3 shows a photograph of polypropylene membranes having attached to them antibodies, one membrane (Tube A, left) having been pre-treated by soaking overnight in carbonate/bicarbonate buffer, and the other (Tube B, right) having been pre-treated by soaking overnight in iso-propanol; and
  • FIG. 4 shows an alternate filter device used in the present invention.
  • Antigens specific to Lactobacillus brevis are well known in the art, for example from Yasui T, and Yoda K. (Appl Environ Microbiol. 1997 November; 63 (11):4528-33; PMID: 9361439), Yasui T, Yoda K. (FEMS Microbiol Lett. 1997 Jun. 15;151(2):169-76; PMID: 9228750), and Shimohashi H, Kodaira S, and Suegara N. (Jpn J Microbiol.
  • a highly concentrated solution of L. brevis micro-organisms was killed by addition of an 8% formaldehyde solution at room temperature for 2-3 hours.
  • the cell pellet was obtained by centrifugation at 12000 rpm for 10 minutes. The liquid was removed and the cell pellet washed and resuspended in sterile deionised water. The centrifugation and washing procedure was repeated until all formaldehyde traces had been removed. Resuspension of the final cell pellet (immunogen) in 0.5 ml PBS and stored frozen until required. Prior to injection of the immunogen 0.125 ml of immunogen was diluted with equal parts Freunds complete adjuvant (Sigma-Aldrich Inc, catalogue number F5881).
  • Hollow fibre polypropylene membranes (Membrana, Wuppertal, Germany; catalogue number PP Q3/2) having a nominal pore size of 0.2 micron and length of 55 cm, were immersed overnight in iso-propanol. The membranes were then dried followed by immersion in Tween-20 (5%) for 20 minutes and then dried.
  • Unbound antibody was then removed by passing air through the lumen of the membrane followed by washing the lumen with several applications of phosphate buffered saline (PBS) containing 0.1% Tween 20 (-50 ml per application). The coated membranes were then allowed to dry completely.
  • PBS phosphate buffered saline
  • TMB tetra methyl benzadine
  • Results are shown in FIG. 3. Darker patches of the membranes 310 , 311 indicate colour change caused by HRP, i.e. the attachment of antibodies to the membrane. Membrane 311 is substantially darker than membrane 310 , indicating that substantially more antibody is attached to it.
  • a 100 ml sample containing a known concentration of L. brevis is passed through the filter device, washed using PBS in 0.1% Tween-20 (as above) to remove unbound micro-organisms and the bound micro-organisms eluted using buffer (typically 0.1 M citric acid pH 3.0). The eluted micro-organisms are then plated onto microbiological plates to determine the level of capture.
  • buffer typically 0.1 M citric acid pH 3.0
  • Filter device 100 comprises a sample inlet 20 having Luer lock fitting 21 communicating with 35 hollow polypropylene fibre membranes 30 having an average pore diameter of 0.2 pm.
  • the first ends of membranes 30 are embedded in UV-curable adhesive which holds them in place and allows then to communicate with sample inlet 20 .
  • the second ends of membranes 30 are embedded in UV-curable adhesive which holds them in place and allows then to communicate with outlet 110 , which is closed by plug 120 , thereby restricting flow through the second ends of membranes 30 .
  • Membranes 30 have been prepared as described in the “Hollow Fibre Membrane Preparation” section above.
  • a 100 ml volume of lager 60 is pumped by peri pump 130 at a rate of 100 ml/minute through tubing 140 into device 100 (the volume of sample such as lager filtered through the device 100 can be increased to e.g. 1000 ml or greater by simply adjusting the surface area of membrane).
  • plug 120 blocking exit 110 causes the only exit from device 100 to be the pores in membranes 30 , and lager 60 is therefore filtered through membranes 30 and the filtrate collected in waste collection vessel 150 and discarded.
  • wash buffer 160 consisting phosphate buffered saline containing 0.01% Tween 20 is pumped through tubing 140 , passing along the lumen of membranes 30 (i.e. not through the pores of the membranes 30 ) and collected in waste vessel 150 and discarded.
  • wash buffer 160 has completed passing through device 100
  • pump 130 is left running for an additional 10 seconds in order to pump air though tubing 140 and membranes 30 to remove excess fluid from membranes 30 .
  • Pump 140 is then turned off and device 100 separated from tubing 140 and pump 130 .
  • a 1 ml sterile syringe containing 0.5 ml of elution buffer 161 (lysis buffer consisting 0.2 M NaOH) is then attached to sample inlet 20 and plunger 55 of syringe 50 fully depressed to flush elution buffer 161 through membranes 30 .
  • Plunger 55 is then drawn back and elution buffer 161 drawn back through the lumen of membranes 30 . This is repeated a further two times to ensure that all bound micro-organisms have been lysed.
  • Plunger 55 is then fully depressed to expel elution buffer 161 into sterile 1.5 ml tube 170 .
  • an equal volume of neutralising buffer (0.2 M Tris phosphate) is added to tube 170 , a lid placed on tube 170 and its contents mixed by inverting tube 170 2-3 times.
  • elution step III could be performed using 0.1 M citric acid pH 3.0 to elute whole micro-organisms into tube 170 without lysis.
  • the most common and rapid method to determine microbial contamination is the measurement of cellular ATP. This requires the breakdown of the cell membrane/wall (cell lysis) in order to release the ATP present in the cell. The released ATP can then be determined using an enzymatic reaction that converts a substrate (luciferin) and ATP into a number of products including light. The amount of light can then be measured using a standard luminometer. A number of ATP assays are commercially available. However, the ability to lyse to completion and therefore release all cellular ATP is micro-organism strain-dependent.
  • Loctite (RTM) 21 semi-automatic controller incorporating hand-held applicator and foot switch, with pressure set to 0.2 bars and digital output to 35.0.
  • Collars (FIG. 2,200) (polycarbonate rod) having internat diameter of 7.0 mm and outer diameter of 12.4 mm.
  • Y-shaped end caps made from 2 mm polymer polypropylene, having a wide end (internal diameter 12.4 mm) for receiving collars and a narrow end (internal diameter 4.1 mm) for connection with Luer syringe nozzle.
  • the nozzle of the adhesive applicator is placed in the centre of the membrane bundle and adhesive applied such that it penetrates through the membrane bundle and the nozzle manipulated such that adhesive is applied to all of the of membranes in the area.
  • Adhesive is additionally applied to the outside of the bundle at the position. A collar is then slid and rotated over the membranes at the position such that it contacts the adhesive.
  • loctite primer 770 tot he inside rim of the end caps and around the outside of the device collars. Leave for approximately 1 minute, then apply Loctite fast set adhesive 403 around the outside of each collar and press end caps firmly over collars until bonded.
  • results obtained using the devices and methods of the present invention show that it is possible to achieve the simple, rapid, and accurate detection of a small number of micro-organisms from a large volume of sample liquid.
  • filter device 500 comprises 20 hollow fibre polypropylene membranes 510 of 40 mm length contained in filter body 520 , each of membranes 510 being isolated in a groove in body 520 and held in place at either end by adhesive 530 which is placed on the outside of membranes 510 and which does not enter into the lumen or ends of membranes 510 .
  • Snap-fit end-cap 540 has a connector for tubing 541 so that samples can be fed directly from sample tanks into device 500 .
  • Snap-fit end-cap 550 comprises a foil-sealed cap having a connector for tubing (not shown) which, when the foil seal is intact, means the only route for fluid flow out of device 500 is by filtration through membranes 510 .
  • Outer body 520 of device 500 also comprises a port 560 to which can be attached a vacuum device to further encourage filtration through membranes 510 .
  • an alternative is to use a combination of a glue (such as an epoxy resin) and a centrifuge.
  • a glue such as an epoxy resin
  • a centrifuge e.g. at 750 rpm
  • the membrane bundle can then be inverted and the process repeated so as to seal the other end of the membranes. Additional curing of the adhesive can be achieved by e.g. baking. In order to stop adhesives and membranes becoming stuck in e.g. the centrifuge, parts can be pre-treated by wiping them with a release agent such as Promol K502.
  • the sealed membrane ends can then be cut through the epoxy resin plugs so as to provide a bundle of un-blocked hollow fibre membranes terminating at either end in an epoxy resin plug. This can then be employed in the same way as the bundles made using UV curable adhesive.
  • Examples of useful epoxy resins are the Pur System Adhesive 725A and Pur System Adhesive 725BF.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
US10/467,440 2001-02-05 2002-02-05 Detection of micro-organisms Abandoned US20040096821A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/382,725 US8956880B2 (en) 2001-02-05 2006-05-11 Detection of micro-organisms

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0102790.3 2001-02-05
GB0102790A GB0102790D0 (en) 2001-02-05 2001-02-05 Detection of micro-organisms
GB0126674.1 2001-11-07
GB0126674A GB0126674D0 (en) 2001-11-07 2001-11-07 Detection of micro-organisms
PCT/GB2002/000498 WO2002062941A1 (fr) 2001-02-05 2002-02-05 Detection de micro-organismes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/382,725 Division US8956880B2 (en) 2001-02-05 2006-05-11 Detection of micro-organisms

Publications (1)

Publication Number Publication Date
US20040096821A1 true US20040096821A1 (en) 2004-05-20

Family

ID=26245680

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/467,440 Abandoned US20040096821A1 (en) 2001-02-05 2002-02-05 Detection of micro-organisms
US11/382,725 Expired - Fee Related US8956880B2 (en) 2001-02-05 2006-05-11 Detection of micro-organisms

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/382,725 Expired - Fee Related US8956880B2 (en) 2001-02-05 2006-05-11 Detection of micro-organisms

Country Status (8)

Country Link
US (2) US20040096821A1 (fr)
EP (1) EP1360274B1 (fr)
JP (1) JP4266637B2 (fr)
CN (2) CN1531588A (fr)
AT (1) ATE366301T1 (fr)
DE (1) DE60220989T2 (fr)
ES (1) ES2287254T3 (fr)
WO (1) WO2002062941A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040024343A1 (en) * 2002-04-02 2004-02-05 Cantor Tom L. Methods and devices for treating severe peripheral bacterial infections
US20060166347A1 (en) * 2005-01-27 2006-07-27 Applera Corporation Sample preparation devices and methods
WO2007001915A3 (fr) * 2005-06-20 2009-05-07 Scantibodies Lab Inc Procedes et dispositifs destines a eliminer des pathogenes et des substances nuisibles des liquides organiques
US20110229926A1 (en) * 2010-03-17 2011-09-22 Hitachi Plant Technologies, Ltd. Storing method of measuring apparatus of airborne floating bacteria
US8039206B1 (en) * 1999-08-06 2011-10-18 Millipore Corporation Detection of micro-organisms
US9439416B2 (en) 2005-11-30 2016-09-13 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
US9655360B2 (en) 2004-01-23 2017-05-23 Eden Research Plc Nematicidal compositions and methods of using them
US10383329B2 (en) 2012-11-21 2019-08-20 Eden Research Plc Preservatives
US10638750B2 (en) 2004-05-20 2020-05-05 Eden Research Plc Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them
US10667512B2 (en) 2005-11-30 2020-06-02 Eden Research Plc Terpene-containing compositions and methods of making and using them
CN111748456A (zh) * 2020-07-01 2020-10-09 深圳市核子基因科技有限公司 一种微生物取样装置

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2387130A (en) 2002-04-04 2003-10-08 Fluid Technologies Plc Hollow fibre filter membrane unit with microorganism detector, and associated usage
CN101085977B (zh) * 2007-06-27 2011-05-25 叶大林 微生物限度过滤器
SG174567A1 (en) * 2009-03-25 2011-10-28 Univ Nanyang Tech Apparatus and method for detection of organisms
CN102816683B (zh) * 2012-08-01 2013-10-09 江苏嘉语生物医药技术有限公司 一种生化培养与检测装置及其检测方法
CN204182492U (zh) * 2013-12-05 2015-03-04 刘玥萌 一种离心过滤管
WO2016023612A1 (fr) * 2014-08-14 2016-02-18 Merck Patent Gmbh Boîte de pétri et procédé d'examen microbiologique de liquides par filtration par membrane
CN107271315B (zh) * 2017-06-06 2019-05-28 山东省医疗器械产品质量检验中心 一种敷料透过水蒸气的能力试验方法
CN115023493A (zh) 2020-01-30 2022-09-06 耶路撒冷希伯来大学伊森姆研究发展有限公司 过滤细胞培养基的方法和装置
EP4337755A1 (fr) 2021-05-10 2024-03-20 Future Meat Technologies Ltd. Systèmes et procédés de recyclage de milieu de culture cellulaire
US20230358651A1 (en) * 2022-05-09 2023-11-09 Robert G. Saunders Device Used for Real Time Field Sampling for DNA Extraction

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267053A (en) * 1976-10-15 1981-05-12 Asahi Kasei Kogyo Kabushiki Kaisha Inline intravenous final filter unit
US4547289A (en) * 1983-02-28 1985-10-15 Yoshihiro Okano Filtration apparatus using hollow fiber membrane
US4647377A (en) * 1984-07-24 1987-03-03 Kabushiki Kaisha Ito Tekkousho Filter apparatus
US5139668A (en) * 1989-12-27 1992-08-18 Alberta Research Corporation Hollow fiber bundle element
US5895573A (en) * 1996-10-07 1999-04-20 Prime Water Systems N.V. Ultrafiltration device for domestic/drinking water purification
US6663745B1 (en) * 1999-01-29 2003-12-16 Mykrolis Corporation Method for manufacturing hollow fiber membranes

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706306A (en) * 1971-03-03 1972-12-19 Harold J Berger Combination blood sampling vacuum syringe centrifuge container and specimen cup
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
AU6839587A (en) * 1985-12-10 1987-06-30 Murex Corp. Particle-bound binding component immunoassay
US4808315A (en) * 1986-04-28 1989-02-28 Asahi Kasei Kogyo Kabushiki Kaisha Porous hollow fiber membrane and a method for the removal of a virus by using the same
US4781768A (en) * 1986-10-01 1988-11-01 National Forge Company Full length forging method for producing large section, large mass cylindrical sleeves of alloy 625
CA1325175C (fr) * 1989-05-25 1993-12-14 Asahi Medical Co., Ltd. Separateur compact de plasma; l'appareil correspondant
CA2032959A1 (fr) * 1990-01-22 1991-07-23 Brian A. Snyder Article, trousse et test de type sandwich pour la detection de bacteroides intermedius, bacteroides gingivalis ou actinobacillus actinomycetemcomitans
JPH0775657B2 (ja) * 1990-10-15 1995-08-16 旭化成工業株式会社 中空糸型モジュール
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
DE69230766T2 (de) * 1991-08-07 2000-08-31 Usf Filtration Ltd., South Windsor Konzentration von feststoffen in einer aufschlammung unter anwendung von kohlfasermembranen
US5672481A (en) * 1991-10-23 1997-09-30 Cellpro, Incorporated Apparatus and method for particle separation in a closed field
US5456835A (en) * 1993-11-08 1995-10-10 Hemasure, Inc. Device and process for removing free hemoglobin from blood
EP0775014A1 (fr) * 1994-08-02 1997-05-28 FSM Technologies Ltd. Filtre a membrane
JPH11508813A (ja) * 1995-06-06 1999-08-03 クウォンティック バイオメディカル パートナーズ 血漿を濃縮するための装置及び方法
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US5820767A (en) * 1996-07-29 1998-10-13 Pall Corporation Method for quantitation of microorganism contamination of liquids
WO1998057733A1 (fr) * 1997-06-14 1998-12-23 Akzo Nobel N.V. Module membranaire a membranes en fibres creuses enrobees d'un cote
DE19750215C1 (de) * 1997-11-13 1999-02-04 Sartorius Gmbh Gelatinemembranfilter und Verfahren zu ihrer Herstellung
DE19814715A1 (de) * 1998-04-02 1999-10-07 Sartorius Gmbh Gelatinemembranfilter, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2347004A1 (fr) * 1998-10-19 2000-04-27 Cbd Technologies Ltd. Procede de concentration de micro-organismes au moyen d'une separation par affinite
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
GB2352652A (en) * 1999-08-06 2001-02-07 Fsm Technologies Ltd Pre-treating hollow fibre membranes for micro-organism detection
DE20014311U1 (de) * 2000-08-15 2001-02-15 HEIM Medizintechnik GmbH, 45966 Gladbeck Filteranordnung zum Auftrennen von Blut in Plasma und zelluläre Bestandteile
AU2002357338A1 (en) * 2002-01-09 2003-07-30 Hydranautics Methods for improving filtration performance of hollow fiber membranes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267053A (en) * 1976-10-15 1981-05-12 Asahi Kasei Kogyo Kabushiki Kaisha Inline intravenous final filter unit
US4547289A (en) * 1983-02-28 1985-10-15 Yoshihiro Okano Filtration apparatus using hollow fiber membrane
US4647377A (en) * 1984-07-24 1987-03-03 Kabushiki Kaisha Ito Tekkousho Filter apparatus
US5139668A (en) * 1989-12-27 1992-08-18 Alberta Research Corporation Hollow fiber bundle element
US5895573A (en) * 1996-10-07 1999-04-20 Prime Water Systems N.V. Ultrafiltration device for domestic/drinking water purification
US6663745B1 (en) * 1999-01-29 2003-12-16 Mykrolis Corporation Method for manufacturing hollow fiber membranes

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039206B1 (en) * 1999-08-06 2011-10-18 Millipore Corporation Detection of micro-organisms
US7569025B2 (en) 2002-04-02 2009-08-04 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
US20040024343A1 (en) * 2002-04-02 2004-02-05 Cantor Tom L. Methods and devices for treating severe peripheral bacterial infections
US9655360B2 (en) 2004-01-23 2017-05-23 Eden Research Plc Nematicidal compositions and methods of using them
US10004229B2 (en) 2004-01-23 2018-06-26 Eden Research Plc Nematicidal compositions and methods of using them
US10729130B2 (en) 2004-01-23 2020-08-04 Eden Research Plc Nematicidal compositions and methods of using them
US10638750B2 (en) 2004-05-20 2020-05-05 Eden Research Plc Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them
WO2006081479A3 (fr) * 2005-01-27 2009-06-04 Applera Corp Dispositifs et procedes de preparation d'echantillons
US20060166347A1 (en) * 2005-01-27 2006-07-27 Applera Corporation Sample preparation devices and methods
WO2007001915A3 (fr) * 2005-06-20 2009-05-07 Scantibodies Lab Inc Procedes et dispositifs destines a eliminer des pathogenes et des substances nuisibles des liquides organiques
US9439416B2 (en) 2005-11-30 2016-09-13 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
US10258033B2 (en) 2005-11-30 2019-04-16 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral and L-carvone
US10667512B2 (en) 2005-11-30 2020-06-02 Eden Research Plc Terpene-containing compositions and methods of making and using them
US20110229926A1 (en) * 2010-03-17 2011-09-22 Hitachi Plant Technologies, Ltd. Storing method of measuring apparatus of airborne floating bacteria
US10383329B2 (en) 2012-11-21 2019-08-20 Eden Research Plc Preservatives
CN111748456A (zh) * 2020-07-01 2020-10-09 深圳市核子基因科技有限公司 一种微生物取样装置

Also Published As

Publication number Publication date
DE60220989D1 (de) 2007-08-16
DE60220989T2 (de) 2008-03-13
ES2287254T3 (es) 2007-12-16
WO2002062941A1 (fr) 2002-08-15
ATE366301T1 (de) 2007-07-15
EP1360274B1 (fr) 2007-07-04
US20060188942A1 (en) 2006-08-24
US8956880B2 (en) 2015-02-17
CN102353779A (zh) 2012-02-15
JP4266637B2 (ja) 2009-05-20
EP1360274A1 (fr) 2003-11-12
CN102353779B (zh) 2014-10-15
CN1531588A (zh) 2004-09-22
JP2004526143A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
US8956880B2 (en) Detection of micro-organisms
US20110315625A1 (en) Detection of micro-organisms
CA2176139C (fr) Procede et appareil pour recueillir un echantillon cellulaire contenu dans un echantillon liquidien
JP6782998B2 (ja) 装置
BR112013012967B1 (pt) processo de concentração, dispositivo de concentração adaptado para ligar ou capturar pelo menos um analito celular alvo, kit e processo para a preparação de um dispositivo de concentração adaptado para ligar ou capturar pelo menos um analito celular alvo
US20240238728A1 (en) Isolation and purification method of extracellular vesicles
EP4467639A1 (fr) Procédé de séparation et de purification de vésicules extracellulaires
Mulvany Chapter VII Membrane Filter Techniques in Microbiology
EP0977884B1 (fr) Procede et dispositif d'essais
JP3461556B2 (ja) 中空糸を用いた微生物の検査方法
US5116736A (en) Method for the quantitative determination of micro-organisms or pyrogens
JPS5840120A (ja) 「あ」過装置
CA2058983A1 (fr) Procede de sterilisation de l'eau
HK40081265A (en) Liquid to liquid biological particle concentrator with disposable fluid path
EP0796140A2 (fr) Procede de traitement de membranes
Waterhouse The retention testing of sterilising grade membranes with Pseudomonas diminuta

Legal Events

Date Code Title Description
AS Assignment

Owner name: MICAP PLC, GREAT BRITAIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KEENAN, ELIZABETH ANN;BRENNAND, MICHAEL S.;REEL/FRAME:015018/0432;SIGNING DATES FROM 20031006 TO 20031014

AS Assignment

Owner name: MILLIPORE CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICAP PLC;REEL/FRAME:019504/0806

Effective date: 20061115

AS Assignment

Owner name: EMD MILLIPORE CORPORATION, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:MILLIPORE CORPORATION;REEL/FRAME:027620/0891

Effective date: 20120101

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION